XML 53 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurement of Assets and Liabilities
3 Months Ended
Mar. 31, 2014
Fair Value Disclosures [Abstract]  
Fair Value Measurement of Assets and Liabilities
Fair Value Measurement of Assets and Liabilities

The following tables summarize our financial assets and liabilities measured at fair value on a recurring basis as of March 31, 2014 and December 31, 2013:

 Description
 
Balance as of
March 31, 2014
 
Quoted Prices in
Active Markets for
Identical Assets
(Level 1) 
 
Significant Other
Observable Inputs
(Level 2)
 
 
(In millions)
Assets:
 
 
 
 
 
 
Cash and cash equivalents
 
$
4,415

 
$
4,355

 
$
60

Short-term investments:
 
 
 
 
 
 
Restricted cash
 
19

 
19

 

Corporate debt securities
 
2,620

 

 
2,620

Government and agency securities
 
9

 

 
9

Equity instruments
 
781

 
781

 

Total short-term investments
 
3,429

 
800

 
2,629

Funds receivable and customer accounts
 
3,458

 

 
3,458

Derivatives
 
21

 

 
21

Long-term investments:
 
 
 
 
 
 
Corporate debt securities
 
4,611

 

 
4,611

Government and agency securities
 
237

 

 
237

Total long-term investments
 
4,848

 

 
4,848

Total financial assets
 
$
16,171

 
$
5,155

 
$
11,016

 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
Derivatives
 
$
119

 
$

 
$
119



Description
 
Balance as of
December 31, 2013
 
Quoted Prices in
Active Markets for
Identical Assets
(Level 1) 
 
Significant Other
Observable Inputs
(Level 2)
 
 
(In millions)
Assets:
 
 
 
 
 
 
Cash and cash equivalents
 
$
4,494

 
$
4,159

 
$
335

Short-term investments:
 
 
 
 
 
 
Restricted cash
 
17

 
17

 

Corporate debt securities
 
3,529

 

 
3,529

Government and agency securities
 
43

 

 
43

Time deposits
 
49

 

 
49

Equity instruments
 
893

 
893

 

Total short-term investments
 
4,531

 
910

 
3,621

Funds receivable and customer accounts
 
3,563

 

 
3,563

Derivatives
 
44

 

 
44

Long-term investments:
 
 
 
 
 
 
Corporate debt securities
 
4,445

 

 
4,445

Government and agency securities
 
251

 

 
251

Total long-term investments
 
4,696

 

 
4,696

Total financial assets
 
$
17,328

 
$
5,069

 
$
12,259

 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
Derivatives
 
$
151

 
$

 
$
151


 
Our financial assets and liabilities are valued using market prices on both active markets (level 1) and less active markets (level 2). Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 instrument valuations are obtained from readily available pricing sources for comparable instruments, identical instruments in less active markets, or models using market observable inputs. The majority of our derivative instruments are valued using pricing models that take into account the contract terms as well as multiple inputs where applicable, such as equity prices, interest rate yield curves, option volatility and currency rates. Our derivative instruments are primarily short-term in nature, generally one month to one year in duration. Certain foreign currency contracts designated as cash flow hedges may have a duration of up to 18 months. We did not have any transfers of financial instruments between valuation levels during the first three months of 2014.

Cash and cash equivalents are short-term, highly liquid investments with original or remaining maturities of three months or less when purchased and are comprised primarily of bank deposits, money market funds and commercial paper. We had total funds receivable and customer accounts of $9.6 billion as of March 31, 2014, of which $3.5 billion was invested in short-term investments.

In addition, we had cost and equity method investments of approximately $357 million and $269 million included in long-term investments on our condensed consolidated balance sheet at March 31, 2014 and our consolidated balance sheet at December 31, 2013, respectively. Additionally, as of both March 31, 2014 and December 31, 2013, we also held $6 million of time deposits classified as held to maturity, which are recorded at amortized cost.

As of March 31, 2014 and December 31, 2013, we held no direct investments in auction rate securities, collateralized debt obligations, structured investment vehicles or mortgage-backed securities.

Other financial instruments, including accounts receivable, loans and interest receivable, accounts payable, funds receivable, certain customer accounts, funds payable and amounts due to customers, are carried at cost, which approximates their fair value because of the short-term nature of these instruments.